Susquehanna International Group, LLP X Biotech Inc. Call Options Transaction History

Susquehanna International Group, LLP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$8.64 - $11.71 $176,256 - $238,884	-20,400 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.95 - $16.07 $17,520 - $25,712	1,600 Added 8.51%	20,400 $227,000
Q3 2020 Nov 16, 2020	BUY	$13.97 - $21.16 $74,041 - $112,148	5,300 Added 39.26%	18,800 $359,000
Q2 2020 Aug 14, 2020	SELL	$10.39 - $16.07 $120,524 - $186,412	-11,600 Reduced 46.22%	13,500 $185,000
Q1 2020 May 15, 2020	SELL	$8.89 - $24.94 $61,341 - $172,086	-6,900 Reduced 21.56%	25,100 $267,000
Q1 2019 May 15, 2019	BUY	$5.05 - $11.62 $108,070 - $248,667	21,400 Added 201.89%	32,000 $353,000
Q2 2018 Aug 14, 2018	SELL	$4.04 - $5.13 $20,200 - $25,650	-5,000 Reduced 32.05%	10,600 $47,000
Q1 2018 May 15, 2018	BUY	$3.92 - $5.35 $5,488 - $7,489	1,400 Added 9.86%	15,600 $83,000
Q4 2017 Feb 14, 2018	SELL	$3.9 - $4.66 $1,560 - $1,864	-400 Reduced 2.74%	14,200 $56,000
Q3 2017 Nov 14, 2017	BUY	$4.14 - $5.12 $60,443 - $74,752	14,600	14,600 $64,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $114M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.